← FDA Drug Approvals (Drugs@FDA)

ORZEYFUL

NDA · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2026-08-05

Drug application

FDA Application #

NDA220860

Application type

New Drug Application

Brand name

ORZEYFUL

Generic name

Oveporexton

Active ingredients

OVEPOREXTON

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

TAKEDA PHARMS USA

First approval

2026-08-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown